source
- FDA CDER chief says expanding generic GLP-1 drugs is top priority to cut American costsMichael Davis, director of the FDA's Center for Drug Evaluation and Research, highlighted that increasing the supply of generic GLP-1 medicines is a key focus for the agency. He noted that broader…
- Trump administration pulls nearly $1 billion from HHS programs for immigrants and diversityThe White House announced a reversal of almost $1 billion in spending that Congress had previously approved for the Department of Health and Human Services. The reduction was made late on Friday ni…